SINOVAC BIOTECH LTD.

(SVA)
  Report
Delayed Nasdaq  -  02/22 04:00:00 pm EST
6.470 USD   -0.31%
05/06SINOVAC Updates the Status Under Holding Foreign Companies Accountable Act
BU
05/02SINOVAC BIOTECH : Press Release - Form 6-K
PU
04/29SINOVAC Reports Unaudited Second Half of 2021 Financial Results and Files 2021 Annual Report on Form 20-F
BU
SummaryQuotesChartsNewsCalendarCompanyFinancials 
Business Summary
Logo Sinovac Biotech Ltd.
Sinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, RabEnd, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine, Rubella Vaccine, Varicella Vaccine and Sabin Inactivated Polio Vaccine.
Managers
Name Title Age Since
Wei Dong Yin, Dr. Chairman, President, CEO, Secretary & MD 57 2003
Nan Wang CFO & Vice President-Business Development 54 2013
Qiang Gao Chief Operating Officer & Vice President 44 2020
Helen G. Yang Investor Relations Contact - -
Xiao Mei Yin Vice President-Sales & Marketing 57 2017
Coco Chang Head-International Sales - -
Members of the board
Name Title Age Since
Wei Dong Yin, Dr. Chairman, President, CEO, Secretary & MD 57 2003
Yuk Lam Lo Independent Director 72 2006
Jian Li Independent Director 52 2011
Meng Mei Independent Director 66 2012
Simon J. Anderson Independent Director 59 2004
Shan Fu Independent Director 54 2018
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 99,502,243 67,108,831 67.4% 0 0.0% 67.4%
Stock B 0 14,630,813 0 0.0% 0 0.0%
Company contact information
Sinovac Biotech Ltd.
Zhongguancun Science & Technology
No. 15 Zhi Tong Road
Changping District
Beijing 102200

Phone : +86.10.5693.1800
Fax : +86.10.5693.1800
Web : http://www.sinovacbio.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Sinovac Biotech Ltd.